The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Anavio partners….. lots of negativity about this outfit from COPL investors who appear to have been stitched up by these guys. Any concern about their involvement here? I am fed up of being royally sh@fted by oilers and don’t want to loose out here too.
Very revealing to read back individuals posting histories. This character was encouraging folk to remortgage their house and stick it all on copl!! All because he has contacts with the most reliable sources of information. Say no more
I invested here heavily on the back of moneysponge’s ramp fest
I paid 150pfor these last year. Sold at a loss when down to 80p. Big hill still to climb as got back in at 55p. I am definitely holding on for more than 40p!!
Oversold and undervalued. Very few pharmas have a phase 3 multinational study under their belts. Slightly underpowered leading to crippling sell off. It is safe, well tolerated and with good evidence of efficacy. Bread crumbs being dropped by the company and Covid is in ascendancy again. Time for a re-rate.
Why are you here? At 180-220p there was risk here and a binary play at that stage. Warning of caution was reasonable. Currently cash in the bank is circa mcap there is little downside risk therefore your presence is not altruistic nor welcome
Https://www.drugdiscoveryonline.com/doc/respiratory-viral-infections-the-next-frontier-for-antiviral-drug-development-0001
What does the board think of the significance of the second reference in this paper. Obviously been presenting at a corporate level this July. Presumably not just in house?